Maculaser has been awarded a 400kEUR Deep Tech Accelerator grant from Business Finland. This brings our total private and public funding for 2023 to 1MEUR and company’s overall funding to 3MEUR. We thank our funders for their support in advancing our mission to develop and commercialize novel retina treatments, ultimately significantly enhancing clinical outcomes.
